MiNK Therapeutics, Inc. Common Stock, Value, Issued
MiNK Therapeutics, Inc. (INKT) had Common Stock, Value, Issued of $52 as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-13
- 2026-06-30: Common Stock, Value, Issued $52.00.
- 2026-03-31: Common Stock, Value, Issued $51.00.
- 2025-12-31: Common Stock, Value, Issued $48.00.
- 2025-09-30: Common Stock, Value, Issued $46.00.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $52.00 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $51.00 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $48.00 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $46.00 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $40.00 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $40.00 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $40.00 10-K · filed 2026-03-31 | |
| 2024-09-30 | $395.00 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $394.00 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $347.00 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $35.00 10-K · filed 2025-03-18 | $346.00 10-K · filed 2024-03-21 |
| 2023-09-30 | $345.00 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $345.00 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $343.00 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $339.00 10-K · filed 2024-03-21 | |
| 2022-09-30 | $338.00 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $337.00 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $336.00 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $335.00 10-K · filed 2023-03-24 | |
| 2021-09-30 | $242.00 10-Q · filed 2021-11-29 | |
| 2020-12-31 | $242.00 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |